Inflammatory lesion and parasite load are inversely associated in Leishmania amazonensis infected mice genetically selected according to oral tolerance susceptibility

Microbes and Infection

Volumn 8, Issue 4, 2006, Pages 957-964

  Tavares, Daniel ^a,b   da Conceição Ribeiro, Ricardo ^a   Carlos da Silva, Antonio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Centro Universitario Celso Lisboa   (Brazil)

Author keywords

Bystander activation; Bystander suppression; Chronic lesion; IFN ; IL 10; IL 4; Leishmania amazonensis; Mice; NO; Parasite load

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; NITRIC OXIDE; OVALBUMIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BYSTANDER EFFECT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE COURSE; EXPERIMENTAL INFECTION; FEMALE; FOOT PAD; GENETIC SUSCEPTIBILITY; GROWTH; IMMUNOREGULATION; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; LEISHMANIA; LEISHMANIASIS; LYMPHOID TISSUE; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMASTIGOTE; SPECIES COMPARISON; SPLEEN CELL; SWELLING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETIC SELECTION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; ORAL DRUG ADMINISTRATION; OUTBRED STRAIN; PARASITE IDENTIFICATION; PARASITOLOGY; PATHOLOGY; PHAGOCYTOSIS; SKIN; SKIN LEISHMANIASIS; SPLEEN;

LEISHMANIA AMAZONENSIS;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, OUTBRED STRAINS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNE TOLERANCE; INFLAMMATION; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; OVALBUMIN; PARASITE EGG COUNT; PHAGOCYTOSIS; SELECTION (GENETICS); SKIN; SPLEEN;

EID: 33746754151     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.09.018     Document Type: Article

References (44)

1. Childs G.E., Lightner L.K., McKinney L., Groves M.G., Price E.E., and Hendricks L.D. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. Ann. Trop. Med. Parasitol. 78 (1984) 25-34
2. DeKrey G.K., Lima H.C., and Titus R.G. Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect. Immun. 66 (1998) 827-829
3. Ji J., Sun J., Qi H., and Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 66 (2002) 338-345
4. Soong L., Chang C.H., Sun J., Longley Jr. B.J., Ruddle N.H., Flavell R.A., and McMahon-Pratt D. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158 (1997) 5374-5383
5. Jones D.E., Buxbaum L.U., and Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165 (2000) 364-372
6. Conceição-Silva F., Dorea R.C., Pirmez C., Schubach A., and Coutinho S.G. Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis. Clin. Exp. Immunol. 79 (1990) 221-226
7. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
8. Sakaguchi S. Regulatory T cells: mediating compromises between host and parasite. Nat. Immunol. 4 (2003) 10-11
9. Zhang X., Izikson L., Liu L., and Weiner H.L. Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J. Immunol. 167 (2001) 4245-4253
10. Barral-Netto M., Barral A., Brownell C.E., Skeiky Y.A., Ellingsworth R., Twardzik D.R., and Reed S.G. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257 (1992) 545-548
11. Padigel U.M., Alexander J., and Farrell J.P. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171 (2003) 3705-3710
12. Jones D.E., Ackermann M.R., Wille U., Hunter C.A., and Scott P. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect. Immun. 70 (2002) 2151-2158
13. Murphy M.L., Wille U., Villegas E.N., Hunter C.A., and Farrell J.P. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31 (2001) 2848-2856
14. Viana Da Costa A., Huerre M., Dlacre M., Auriault C., Costa J.M.C., and Verwaerde C. IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol. Int. 51 (2002) 367-379
15. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174 (1991) 1549-1555
16. Vouldoukis I., Becherel P.A., Riveros-Moreno V., Arock M., da Silva O., Debre P., Mazier D., and Mossalayi M.D. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 27 (1997) 860-865
17. Augusto O., Linares E., and Giorgio S. Possible roles of nitric oxide and peroxynitrite in murine leishmaniasis. Braz. J. Med. Biol. Res. 29 (1996) 853-862
18. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., and Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178 (1993) 1041-1048
19. Macatonia S.E., Doherty T.M., Knight S.C., and O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 150 (1993) 3755-3765
20. Alexander J., Brombacher F., McGachy H.A., McKenzie A.N., Walker W., and Carter K.C. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. Eur. J. Immunol. 32 (2002) 2923-2933
21. Faria A.M., and Weiner H.L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73 (1999) 153-264
22. Rizzo L.V., Morawetz R.A., Miller Rivero N.E., Choi R., Wiggert B., Chan C.C., Morse III H.C., Nussenblatt R.B., and Caspi R.R. IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 162 (1999) 2613-2622
23. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194 (2001) 629-644
24. Miller A., Lider O., and Weiner H. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174 (1991) 791-798
25. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182 (2001) 207-214
26. Tsuji N.M., Mizumachi K., and Kurisaki J. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 103 (2001) 458-464
27. da Silva A.C., de Souza K.W., Machado R.C., da Silva M.F.S., and Sant'Anna O.A. Genetics of immunological tolerance: I. Bidirectional selective breeding of mice for oral tolerance. Res. Immunol. 149 (1998) 151-161
28. Kamphorst A.O., da Silva M.F.S., da Silva A.C., Carvalho C.R., and Faria A.M.C. Genetic selection for resistance or susceptibility to oral tolerance to ovalbumin affects general mechanisms of tolerance induction in mice. Ann. N.Y. Acad. Sci. 1029 (2004) 350-354
29. da Silva M.F.S., da Nóbrega A., Barja-Fidalgo T.C., Brando-Lima A.C., Cunha F., and da Silva A.C. Genetic selection for susceptibility to oral tolerance leads to a profound reduction of the acute inflammatory response. Ann. N.Y. Acad. Sci. 1029 (2004) 398-401
30. da Silva M.F., da Costa S.C., Ribeiro R.C., Sant'Anna O.A., and da Silva A.C. Independent genetic control of B- and T-cell tolerance in strains of mouse selected for extreme phenotypes of oral tolerance. Scand. J. Immunol. 53 (2001) 148-154
31. Afonso L.C., and Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61 (1993) 2952-2959
32. da Silva A.C., Bezerra L.M., Aguiar T.S., Tavares D., Araujo L.M., Pinto C.E., and Ribeiro O.G. Effect of genetic modifications by selection for immunological tolerance on fungus infection in mice. Microbes Infect. 3 (2001) 215-222
33. Fahey III T.J., Tracey K.J., Tekamp-Olson P., Cousens L.S., Jones W.G., Shires G.T., Cerami A., and Sherry B. Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148 (1992) 2764-2769
34. Green L.C., Tannenbaum S.R., and Goldman P. Nitrate synthesis in the germfree and conventional rat. Science 212 (1981) 56-58
35. de Freitas Balanco J.M., Moreira M.E., Bonomo A., Bozza P.T., Amarante-Mendes G., Pirmez C., and Barcinski M.A. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr. Biol. 11 (2001) 1870-1873
36. Seabra S.H., de Souza W., and Damatta R.A. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta 1 autocrine effect orchestrating macrophage evasion. Biochem. Biophys. Res. Commun. 324 (2004) 744-752
37. Dhaliwal J.S., Liew F.Y., and Cox F.E. Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis. Infect. Immun. 49 (1985) 417-423
38. Hori S., Carvalho T.L., and Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32 (2002) 1282-1291
39. Xu D., Liu H., Komai-Koma M., Campbell C., Charlie McS., Alexander J., and Liew F.Y. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170 (2003) 394-399
40. Lonardoni M.V.C., Russo M., and Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect. Immun. 68 (2000) 6355-6361
41. Qi H., Ji J., Wanasen N., and Soong L. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect. Immun. 72 (2004) 988-995
42. Andrade R.M., Portillo J.-A.C., Wessendarp M., and Subauste C.S. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates. Infect. Immun. 73 (2005) 3115-3123
43. Ji J., Sun J., and Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 71 (2003) 4278-4288
44. Ehl S., Hombach J., Aichele P., Hengartner H., and Zinkernagel R.M. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 185 (1997) 1241-1252